vs
Ellington Financial Inc.（EFC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Ellington Financial Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.0倍（$78.2M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 8.7%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 1.8%）
埃林顿金融是一家美国对冲基金机构，专注于结构化产品及其他信贷工具领域的投资管理。截至2019年6月，公司公开披露的管理资产规模达85亿美元，在另类投资和信用资管领域拥有成熟的运营经验。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
EFC vs PBYI — 直观对比
营收规模更大
EFC
是对方的1.0倍
$75.5M
营收增速更快
PBYI
高出19.0%
8.7%
两年增速更快
PBYI
近两年复合增速
1.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $78.2M | $75.5M |
| 净利润 | $22.6M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 7.4% | 22.7% |
| 净利率 | 28.9% | — |
| 营收同比 | 8.7% | 27.7% |
| 净利润同比 | -26.2% | — |
| 每股收益（稀释后） | $0.10 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EFCPBYI
| Q4 25 | $78.2M | $75.5M | ||
| Q3 25 | $82.8M | $54.5M | ||
| Q2 25 | $92.5M | $52.4M | ||
| Q1 25 | $82.9M | $46.0M | ||
| Q4 24 | $72.0M | $59.1M | ||
| Q3 24 | $67.0M | $80.5M | ||
| Q2 24 | $91.2M | $47.1M | ||
| Q1 24 | $75.5M | $43.8M |
净利润EFCPBYI
| Q4 25 | $22.6M | — | ||
| Q3 25 | $29.5M | $8.8M | ||
| Q2 25 | $42.9M | $5.9M | ||
| Q1 25 | $31.6M | $3.0M | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $16.2M | $20.3M | ||
| Q2 24 | $52.3M | $-4.5M | ||
| Q1 24 | $26.9M | $-4.8M |
毛利率EFCPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率EFCPBYI
| Q4 25 | 7.4% | 22.7% | ||
| Q3 25 | 31.1% | 17.6% | ||
| Q2 25 | 38.3% | 12.7% | ||
| Q1 25 | 37.3% | 8.7% | ||
| Q4 24 | 28.0% | 22.6% | ||
| Q3 24 | 24.0% | 27.4% | ||
| Q2 24 | 52.8% | -4.6% | ||
| Q1 24 | 42.2% | -5.3% |
净利率EFCPBYI
| Q4 25 | 28.9% | — | ||
| Q3 25 | 35.7% | 16.2% | ||
| Q2 25 | 46.4% | 11.2% | ||
| Q1 25 | 38.2% | 6.5% | ||
| Q4 24 | 42.6% | — | ||
| Q3 24 | 24.1% | 25.2% | ||
| Q2 24 | 57.4% | -9.6% | ||
| Q1 24 | 35.6% | -11.0% |
每股收益（稀释后）EFCPBYI
| Q4 25 | $0.10 | $0.26 | ||
| Q3 25 | $0.29 | $0.17 | ||
| Q2 25 | $0.45 | $0.12 | ||
| Q1 25 | $0.35 | $0.06 | ||
| Q4 24 | $0.23 | $0.40 | ||
| Q3 24 | $0.19 | $0.41 | ||
| Q2 24 | $0.62 | $-0.09 | ||
| Q1 24 | $0.32 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $201.9M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $1.8B | $130.3M |
| 总资产 | $19.4B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资EFCPBYI
| Q4 25 | $201.9M | $97.5M | ||
| Q3 25 | $184.8M | $94.4M | ||
| Q2 25 | $211.0M | $96.0M | ||
| Q1 25 | $203.3M | $93.2M | ||
| Q4 24 | $192.4M | $101.0M | ||
| Q3 24 | $217.7M | $96.7M | ||
| Q2 24 | $198.5M | $96.8M | ||
| Q1 24 | $187.5M | $107.2M |
总债务EFCPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益EFCPBYI
| Q4 25 | $1.8B | $130.3M | ||
| Q3 25 | $1.8B | $115.3M | ||
| Q2 25 | $1.7B | $104.7M | ||
| Q1 25 | $1.6B | $97.1M | ||
| Q4 24 | $1.6B | $92.1M | ||
| Q3 24 | $1.6B | $71.1M | ||
| Q2 24 | $1.6B | $48.5M | ||
| Q1 24 | $1.5B | $51.0M |
总资产EFCPBYI
| Q4 25 | $19.4B | $216.3M | ||
| Q3 25 | $17.8B | $202.9M | ||
| Q2 25 | $17.1B | $194.9M | ||
| Q1 25 | $16.6B | $196.2M | ||
| Q4 24 | $16.3B | $213.3M | ||
| Q3 24 | $16.0B | $220.7M | ||
| Q2 24 | $15.1B | $205.0M | ||
| Q1 24 | $15.1B | $214.1M |
负债/权益比EFCPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-925.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | -40.92× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流EFCPBYI
| Q4 25 | $-925.5M | $14.4M | ||
| Q3 25 | $-290.4M | $9.7M | ||
| Q2 25 | $-210.5M | $14.1M | ||
| Q1 25 | $-126.4M | $3.6M | ||
| Q4 24 | $-430.5M | $15.6M | ||
| Q3 24 | $-141.7M | $11.0M | ||
| Q2 24 | $-88.6M | $1.0M | ||
| Q1 24 | $-59.5M | $11.2M |
自由现金流EFCPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率EFCPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度EFCPBYI
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率EFCPBYI
| Q4 25 | -40.92× | — | ||
| Q3 25 | -9.84× | 1.10× | ||
| Q2 25 | -4.90× | 2.41× | ||
| Q1 25 | -3.99× | 1.21× | ||
| Q4 24 | -14.04× | — | ||
| Q3 24 | -8.76× | 0.54× | ||
| Q2 24 | -1.69× | — | ||
| Q1 24 | -2.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
